Table 1.
Characteristics | ED Enrolled (n=20) | PIER1, 7-days (n=7) | PIER1, 14-days (n=5) | PIER1, 21-days (n=3) | PIER1, 28-days (n=2) |
---|---|---|---|---|---|
Age, mean (SD) | 22 (1.8) | 32.7 (11) | 38.4 (8.0) | 49.3 (8.1) | 31 (11.3) |
Age, range | 21–56 | 22–56 | 29–49 | 40–55 | 23–39 |
Female, n (%) | 11 (55%) | 5 (71.4%) | 4 (80%) | 0 | 1 (50%) |
Race, n(%) | |||||
White/Caucasian | 15 (75%) | 6 (85.7%) | 3 (60%) | 2 (66.7%) | 2 (100%) |
African American | 2 (10%) | 0 | 1 (20%) | 0 | 0 |
Other | 3 (15%) | 1 (14.4%) | 1 (20%) | 1 (33.3%) | 0 |
Hispanic ethnicity, n (%) | 0 | ||||
Education | |||||
Did not complete high school | 2 (10%) | 1 (14.3%) | 0 | 0 | 1 (50%) |
High school graduate or GED | 9 (45%) | 4 (57.1%) | 1 (20%) | 1 (33%) | 0 |
Some college | 6 (30%) | 2 (28.6%) | 1 (20%) | 2 (66.7%) | 1 (50%) |
Post-graduate degree | 2 (10%) | 0 | 2 (40%) | 0 | 0 |
Vocational | 3 (15%) | 0 | 1 (20%) | 0 | 0 |
Occupation | |||||
Stay-at-home parent | 2 (10%) | 1 (14.3) | 1 (20%) | 0 | 0 |
Labor | 8 (40%) | 2 (28.6%) | 2 (40%) | 2 (66.7%) | 0 |
None | 10 (50%) | 4 (57.1%) | 2 (40%) | 1 (33.3%) | 2 (100%) |
Past treatment for substance use | |||||
Never, n(%) | 2 (10%) | 1 (16.7%) | 0 | 0 | 1 (50%) |
Median (IQR) | 3 (1–4) | 2 (1–4) | 5 (2–6) | 3 (2–3) | 4 (0–8) |
Opioid Use Dependence (RODS score=7) | 12 (60%) | 4 (57.1%) | 4 (80%) | 1 (33.3%) | 1 (50%) |
Opioid use | |||||
Prescriptions | 14 (70%) | 4 (57.1%) | 4 (80%) | 3 (100%) | 2 (100%) |
Heroin | 18 (90%) | 7 (100%) | 5 (100%) | 1 (33.3%) | 2 (100%) |
Other drug use, n (%) | |||||
At least daily tobacco | 14 (70%) | 5 (71.4) | 5 (100%) | 1 (33.3%) | 2 (100%) |
Any cannabis | 10 (50%) | 5 (73.4%) | 1 (20%) | 1 (33.3%) | 1 (50%) |
Any cocaine | 11 (55%) | 5 (73.4%) | 3 (60%) | 1 (33.3%) | 1 (50%) |
Any stimulants | 7 (35%) | 3 (42.0%) | 2 (40%) | 0 | 1 (50%) |
Any sedatives | 13 (65%) | 5 (73.4%) | 1 (20%) | 2 (66.7%) | 1 (50%) |
Stage of Change, Median (IQR) scores | |||||
Recognition | 27 (24–28) | 28 (21–28) | 25 (24–28) | 27 (23–28) | 26.5 (26–27) |
Ambivalence | 12 (10–13) | 12 (10–15) | 11 (8–12) | 13 (11–14) | 11 (7–15) |
Taking Steps | 26 (21–18) | 24 (20–27) | 26 (24–28) | 26 (13–29) | 22 (16–28) |